Contraceptive Technology Update – March 1, 2020
March 1, 2020
View Issues
-
Progesterone After Mifepristone to Halt Medication Abortion: Is It Safe?
Results of a new study indicated that women who initiate medication abortion but opt to stop in the middle of treatment may be at risk for serious blood loss.
-
Help Women Take Charge of Breast Cancer Risks
About one in three breast cancer cases could be prevented by lifestyle modifications such as weight management, exercise, diet, and alcohol consumption, according to a recent presentation at the North American Menopause Society 2019 Annual Meeting.
-
Postpartum LARC: Highly Effective, but Restricted by Some Hospitals
Women who receive care in Catholic facilities may be denied postpartum LARC due to religious directives that ban such care. In 10 states, more than 30% of all hospital beds are in Catholic facilities. In about 50% of states, more than one in five hospital beds is in a Catholic facility.
-
Research Examines Effect of Pregnancy Preferences on Contraceptive Use
Researchers found that women with a strong preference to avoid pregnancy were far more likely to use any contraceptive method. However, more than 50% of women who reported a low preference to avoid pregnancy used some form of birth control.
-
Check Your Practice: Are Unnecessary Pelvic Exams and Pap Tests Being Performed?
While pelvic examinations and cervical cancer screenings are no longer recommended for most young women under age 21 years during routine health visits, results from a new national study indicate that millions of women are undergoing these tests unnecessarily.
-
Consensus Position Statement on the Use of Testosterone in Women
Clinicians lack clearly established guidance and indications for testosterone therapy for women, which has led to considerable variation in practice patterns. The absence of clear indications and approved products for women has resulted in the use of compounded therapies or off-label prescription of testosterone formulations approved for men.
-
New Congressional Funding for STD Programs: Is It Enough?
Congress recently increased federal funding for sexually transmitted disease (STD) prevention for the first time since 2003, with a $3.51 million addition in base funding to the CDC’s STD prevention programs. But is the funding enough to fully address the rise in national STD rates?
-
More Young Adults Receiving HPV Vaccination, but There Is Room for Improvement
Results of a new report indicate that the percentage of adults ages 18-26 years who received one or more doses of human papillomavirus (HPV) vaccine nearly doubled between 2013 and 2018. The percentage of adults in the same age category who received the recommended number of doses of HPV vaccine increased from 13.8% to 21.5%.